Portfolio Companies 2026 for Enavate Sciences: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Enavate Sciences accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $1.1B. The median disclosed raise is $179M, and the largest is BridgeBio Oncology Therapeutics at $200M, ahead of Braveheart Bio ($190M) and Sudo Biosciences ($188M).
The names that recur most often on these portfolio cap tables are Enavate Sciences (8 companies), Frazier Life Sciences (2 companies), Patient Square Capital (2 companies), Cormorant Asset Management (1 company), Omega Funds (1 company), Deerfield Management (1 company). By latest disclosed round, the market skews Series A (4), Series B (2), Growth (1), Series C (1).
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide